Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 16, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference

DURHAM, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will...
March 10, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
March 01, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

DURHAM, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that the US Food and Drug...
February 28, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Appoints Mark Singleton as Chief Financial Officer

DURHAM, N.C., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has appointed...
February 22, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

DURHAM, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
January 11, 2022 07:00 ET | Source: Bioventus, Inc.

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today preliminary revenue...
December 28, 2021 07:00 ET | Source: Bioventus, Inc.

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present...
December 21, 2021 09:25 ET | Source: Bioventus, Inc.

Bioventus Appoints Michelle McMurry-Heath to Board of Directors

DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has announced the appointment of...
December 20, 2021 08:30 ET | Source: Bioventus, Inc.

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

DURHAM, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced the US Food and Drug...
November 18, 2021 08:45 ET | Source: Bioventus, Inc.

Bioventus to Expand Operations and Manufacturing in Memphis

MEMPHIS, Tenn., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has signed a lease agreement to...